Moderna announces fda authorization of third dose of covid-19 vaccine for immunocompromised individuals

Cambridge, mass.--(business wire)--moderna announces fda authorization of third dose of covid-19 vaccine for immunocompromised individuals.

MRNA Ratings Summary

MRNA Quant Ranking